Organized by

Organizer Jungmin Choi (Korea University)
Chair Hong-Hee Won (Sungkyunkwan University), Jongbum Jeon (KOBIC)

This session will address recent advances in sequencing technologies, multi-omics integration, and AI-supported data analysis. Presentations will highlight practical considerations for population-scale genomics, emerging research applications, and examples of data interpretation enabled by analytic platforms. The session aims to provide researchers and clinicians with an overview of end-to-end genomic workflows and their potential impact on future precision medicine.

The Yonsei University NRL 2.0 Bio-Centennial Convergence Institute will host a special session dedicated to translational research focused on aging and age-related diseases, showcasing a wide spectrum of innovative efforts aimed at bridging fundamental discoveries with clinical and commercial applications. This session will highlight cutting-edge research addressing the biological mechanisms of aging as well as therapeutic strategies targeting age-associated conditions such as cardiovascular diseases, metabolic syndromes, and cancer. Speakers will present diverse translational approaches, ranging from early-stage laboratory findings to preclinical development and clinical validation, illustrating how foundational science can evolve into impactful medical solutions.

In addition to scientific presentations, the program will include in-depth discussions on strategies for commercialization, intellectual property development, industry collaboration, regulatory pathways, and sustainable innovation models. Participants will explore practical frameworks for transforming academic discoveries into viable therapeutics, diagnostics, and biomedical technologies that address the growing global burden of aging populations.

A keynote lecture will be delivered by Professor Daria Mochly-Rosen of Stanford Medicine, Director of the Stanford SPARK program. She will share insights into the SPARK model, which has successfully accelerated the translation of university-based discoveries into real-world therapies and startup ventures. Her talk will provide a valuable perspective on building effective translational ecosystems, fostering academia–industry partnerships, and nurturing investigator-driven innovation.

This session is designed for researchers, clinicians, trainees, and innovators at all career stages who are interested in translational science. It will be particularly relevant to scientists seeking to connect basic research with practical implementation and commercialization. By fostering dialogue across disciplines and generations, the event aims to inspire a collaborative community committed to advancing discoveries in aging and age-related diseases into meaningful biomedical advances and societal impact.

Organized by

Organizer Mee-Hyun Lee (College of Korean Medicine, Dongshin University)
Chair Yung Hyun Choi (College of Korean Medicine, Dongeui University), Ki-Tae Ha (School of Korean Medicine, Pusan National University)

This session aims to reinterpret the traditional concept of Bi–Wi imbalance from a molecular perspective based on microbiome, metabolome, and multi-omics approaches. By doing so, we seek to advance the understanding of disease pathophysiology and explore its potential expansion into evidence-based integrative therapeutic strategies. Furthermore, this session will propose a novel research paradigm bridging traditional Korean medicine and modern life sciences through interdisciplinary discussions encompassing basic research, clinical studies, and industrial applications.

생명과학 연구는 그 어느 때보다 빠르게 진화하고 있습니다. 유전체 시퀀싱 비용이 급격히 하락하면서 데이터는 폭발적으로 증가했고, 임상 데이터, 다중오믹스, 의료 영상, 문헌 정보 등 이질적인 데이터를 통합 분석해야 하는 복잡성은 오히려 심화되고 있습니다. 전통적인 연구 파이프라인은 각 단계가 분절되어 있어, 바이오마커 발굴에서 임상 적용까지 수년에서 수십 년이 소요되는 실정입니다. 이 병목을 해소하려면 두 가지가 동시에 필요합니다. 첫째, 페타바이트 규모의 데이터를 처리할 수 있는 확장 가능한 연구 인프라. 둘째, 복잡한 분석 워크플로우를 자율적으로 수행할 수 있는 지능형 에이전트 입니다.

TBA

Organized by

Organizer & Chair Jaechul Lim (Seoul National University)

This session will explore cutting-edge advances in RNA technologies and their integration with multi-omics approaches to better understand complex biological systems. The program will highlight how synthetic RNA platforms are enabling precise cell programming and functional modulation. It will also cover the application of RNA sequencing in immunology, providing deeper insights into immune cell dynamics and mechanisms. In addition, the session will introduce the latest multi-omics strategies accelerating cancer discovery and translational research. Together, these talks offer a comprehensive view of how RNA and multi-omics are reshaping modern biomedical research.